MedPath

Multicenter Study of Circulating Tumor DNA in Patients with Pancreatic Cancer Using a Personalized Panel

Not Applicable
Recruiting
Conditions
Resectable and unresectable pancreatic cancer
Registration Number
JPRN-UMIN000043561
Lead Sponsor
ational Cancer Center Hospital East
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Common exclusion criteria for both the unresectable and resectable pancreatic cancer patient cohorts 1.Synchronous double/multiple cancer or metachronous double/multiple cancer with progression free period of 2 years or shorter. 2.Women who are pregnant or planning to become pregnant. 3.Judged by the investigator as being unsuitable for participation in the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath